Antibody Infusions to Prevent HIV Acquisition
The AMP Studies aimed to establish whether infusions of bNAb called VRC01 are an effective and safe way to prevent HIV acquisition.
The AMP Studies aimed to establish whether infusions of bNAb called VRC01 are an effective and safe way to prevent HIV acquisition.
Innovations such as accurate, rapid, point-of-care tests are needed to regain traction against increasing rates of sexually transmitted infections.
A single 500 mg intramuscular dose of ceftriaxone is recommended for treatment of uncomplicated urogenital, anorectal, and pharyngeal gonorrhea.
Many sexually active men who have sex with men (MSM) do not receive recommended prevention services and sexually transmitted disease (STD) testing when receiving care for HIV infection.
The Centers for Disease Control and Prevention released recommendations for providing quality clinical services for sexually transmitted diseases.
Crowd diagnosis of sexually transmitted diseases (STDs) is common online.
Most office-based physicians who provide STI services report not having on-site access to the recommended injectable medications for same-day treatment of gonorrhea and syphilis.
Investigators of this study sought to compare the efficacy of a community health nursing intervention vs standard of care to improve self-management of pelvic inflammatory disease.
Investigators found a decline in pediatric herpes zoster incidence and a significantly lower incidence among vaccinated children.
The FDA has granted 510(k) clearance to binx io for a molecular point-of-care diagnostic testing platform for detecting chlamydia and gonorrhea in approximately 30 minutes.